1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of the Ear Infection
4.2.2 Increasing Exposure to Cigarette Smoke
4.3 Market Restraints
4.3.1 High Cost and Complications related Surgical Procedures
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Infection
5.1.1 Inner Ear Infection
5.1.2 Middle Ear Infection
5.1.3 Outer Ear Infection
5.2 By Cause
5.2.1 Viral Infection
5.2.2 Bacterial Infection
5.3 By Type
5.3.1 Medication
5.3.1.1 Antibiotics
5.3.1.2 Analgesics
5.3.1.3 AntiViral
5.3.2 Surgery
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Olympus Corporation
6.1.2 American Diagnostic Corporation
6.1.3 Pfizer plc
6.1.4 Novartis AG
6.1.5 Grace Medical
6.1.6 Sanofi S.A.
6.1.7 GlaxoSmithKline plc
6.1.8 Johnson & Johnson
6.1.9 Cipla Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Companies Mentioned
 - Olympus Corporation
- American Diagnostic Corporation
- Pfizer plc
- Novartis AG
- Grace Medical
- Sanofi S.A.
- GlaxoSmithKline plc
- Johnson & Johnson
- Cipla Ltd